Osteoblasts: novel roles in orchestration of skeletal architecture

Aubin, J. E., & Triffitt, J. T. (2002). Mesenchymal stem cells and osteoblast differentiation. In J. P. Bilezikian, L. G. Raisz, & G.A. Rodan (Eds.), Principles of bone biology (Vol. 1, pp. 59–81). San Diego: Academic Press.

Boyden, 2002, High bone density due to a mutation in LDL-receptor-related protein 5, N. Engl. J. Med., 346, 1513, 10.1056/NEJMoa013444

Gehron Robey, P. (2002). Bone matrix proteoglycans and glycoproteins. In J. P. Bilezikian, L. G. Raisz, & G. A. Rodan (Eds.), Principles of bone biology (Vol. 1, pp. 225–237). San Diego: Academic Press.

Gong, 2001, LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development, Cell, 107, 513, 10.1016/S0092-8674(01)00571-2

Hock, J. M., Fitzpatrick, L. A., & Bilezikian, J. B. (2002). Actions of parathyroid hormone. In J. P. Bilezikian, L. G. Raisz, & G. A. Rodan (Eds.), Principles of bone biology (Vol. 1, pp. 463–481). San Diego: Academic Press.

Jilka, 1999, Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone, J. Clin. Invest., 104, 439, 10.1172/JCI6610

Kato, 2002, Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in LRP5, a Wnt coreceptor, J. Cell Biol., 157, 303, 10.1083/jcb.200201089

Little, 2002, A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait, Am. J. Hum. Genet., 70, 11, 10.1086/338450

Mackie, 1996, Modulation of osteoblast behaviour by tenascin, J. Cell. Sci., 109, 1597, 10.1242/jcs.109.6.1597

Marks, S. C., & Odgren, P. R. (2002). Structure and development of the skeleton. In J. P. Bilezikian, L. G. Raisz, & G. A. Rodan (Eds.), Principles of bone biology (Vol. 1, pp. 3–15). San Diego: Academic Press.

Prêle, 2003, Identification of the molecular mechanisms contributing to polarized trafficking in osteoblasts, Exp. Cell. Res., 282, 24, 10.1006/excr.2002.5668

Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321

Takeda, 2002, Leptin regulates bone formation via the sympathetic nervous system, Cell, 111, 305, 10.1016/S0092-8674(02)01049-8

Udagawa, 1999, Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: Receptor activator of NF-kappa B ligand, Bone, 25, 517, 10.1016/S8756-3282(99)00210-0

Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proc. Natl. Acad. Sci. U.S.A., 95, 3597, 10.1073/pnas.95.7.3597